Sino Biopharmaceutical Ltd. financial statements, including revenue, expenses, profit, and loss
The total revenue of SBMFF for the last semiannual is 1.51 B USD, and it's 31.46% lower compared to the previous semiannual. The net income of H2 23 is 81.38 M USD.